Low serum total cholesterol is associated with marked increase in mortality in advanced heart failure.

[1]  R. Levy,et al.  Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge. , 1972, Clinical chemistry.

[2]  R. Goldberg,et al.  Combined effects of HDL cholesterol, triglyceride, and total cholesterol concentrations on 18-year risk of atherosclerotic disease. , 1995, Circulation.

[3]  F. Tristani,et al.  Ejection Fraction, Peak Exercise Oxygen Consumption, Cardiothoracic Ratio, Ventricular Arrhythmias, and Plasma Norepinephrine as Determinants of Prognosis in Heart Failure , 1993, Circulation.

[4]  W. Vaughn,et al.  Low Serum Cholesterol Levels Predict High Perioperative Mortality in Patients Supported by a Left-Ventricular Assist System , 1998, Cardiology.

[5]  L. Wilhelmsen,et al.  Heart failure in the general population of men--morbidity, risk factors and prognosis. , 2001, Journal of internal medicine.

[6]  G. Fonarow,et al.  Skin test anergy in advanced heart failure secondary to either ischemic or idiopathic dilated cardiomyopathy. , 1998, The American journal of cardiology.

[7]  L. Stevenson,et al.  Prevalence and hemodynamic correlates of malnutrition in severe congestive heart failure secondary to ischemic or idiopathic dilated cardiomyopathy. , 1989, The American journal of cardiology.

[8]  P. Fraunberger,et al.  Serum cholesterol and mortality in patients with multiple organ failure. , 2000, Critical care medicine.

[9]  L. Kuller,et al.  Predictors of mortality from idiopathic dilated cardiomyopathy in 356,222 men screened for the Multiple Risk Factor Intervention Trial. , 1994, American journal of epidemiology.

[10]  M. Netea,et al.  Low-density lipoprotein receptor-deficient mice are protected against lethal endotoxemia and severe gram-negative infections. , 1996, The Journal of clinical investigation.

[11]  P. Galuppo,et al.  Improvement of Left Ventricular Remodeling and Function by Hydroxymethylglutaryl Coenzyme A Reductase Inhibition With Cerivastatin in Rats With Heart Failure After Myocardial Infarction , 2001, Circulation.

[12]  S. Anker,et al.  The endotoxin-lipoprotein hypothesis , 2000, The Lancet.

[13]  K. Yano,et al.  Cholesterol and all-cause mortality in elderly people from the Honolulu Heart Program: a cohort study , 2001, The Lancet.

[14]  J Pekkanen,et al.  Ten-year mortality from cardiovascular disease in relation to cholesterol level among men with and without preexisting cardiovascular disease. , 1990, The New England journal of medicine.

[15]  S. Anker,et al.  Inflammatory cytokines and the possible immunological role for lipoproteins in chronic heart failure. , 2000, International journal of cardiology.

[16]  M. Luu,et al.  Importance of hemodynamic response to therapy in predicting survival with ejection fraction ≤ 20% secondary to ischemic or nonischemic dilated cardiomyopathy , 1990 .

[17]  G. Fonarow,et al.  Impact of a comprehensive heart failure management program on hospital readmission and functional status of patients with advanced heart failure. , 1997, Journal of the American College of Cardiology.

[18]  E. Meilahn.  Low serum cholesterol. Hazardous to health? , 1995, Circulation.

[19]  R. Kronmal,et al.  Modifiable risk factors for incident heart failure in the coronary artery surgery study. , 1994, Archives of internal medicine.

[20]  A J Belanger,et al.  Epidemiology of heart failure. , 1991, American heart journal.

[21]  K. Feingold,et al.  Role for circulating lipoproteins in protection from endotoxin toxicity , 1995, Infection and immunity.

[22]  P. Edwards,et al.  The role of lipoproteins and receptor-mediated endocytosis in the transport of bacterial lipopolysaccharide. , 1986, Proceedings of the National Academy of Sciences of the United States of America.

[23]  Elliott Dc,et al.  Low lipid concentrations in critical illness: hypocholesterolemia among trauma patients. , 1997 .

[24]  P. Ponikowski,et al.  Wasting as independent risk factor for mortality in chronic heart failure , 1997, The Lancet.

[25]  B. Chernow.  Variables affecting outcome in critically ill patients. , 1999, Chest.

[26]  K. Werdan,et al.  Reduction of Circulating Cholesterol and Apolipoprotein Levels during Sepsis , 1999, Clinical chemistry and laboratory medicine.

[27]  D. Wagner,et al.  The role of tumor necrosis factor in the pathophysiology of heart failure. , 2000, Journal of the American College of Cardiology.

[28]  P. Poole‐Wilson,et al.  Acute coronary findings at autopsy in heart failure patients with sudden death: results from the assessment of treatment with lisinopril and survival (ATLAS) trial. , 2000, Circulation.

[29]  G. Fonarow,et al.  The relationship between obesity and mortality in patients with heart failure. , 2001, Journal of the American College of Cardiology.